drugset / Trial / NCT00731302
Aspirin Resistance in Systemic Lupus Erythematosus (SLE)
Phase 1
Completed
70 enrolled
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI) · collab
NaSingle-groupOpen-labelOther
Summary
This study examine whether patients with lupus respond to aspirin , and if not, if that is related to inflammation. We examine the ability of aspirin to inhibit the production of thromboxane in patients with lupus and controls and see if aspirin insensitive thromboxane production is inhibited by meloxicam.
Timeline
- Start
- 2005-04
- Primary completion
- 2017-04
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 81 mg | — |
| Subject | Meloxicam | Small molecule | 7.5 mg | — |